本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nascent Biotech Inc.

0.0003
-0.0001-25.00%
成交量:3,250.00
成交額:0.97
市值:5.19萬
市盈率:-0.03
高:0.0003
開:0.0003
低:0.0003
收:0.0004
52周最高:0.1345
52周最低:0.0000
股本:1.73億
流通股本:8,608.38萬
量比:0.06
換手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-0.0118
每股收益(LYR):-0.0134
淨資產收益率:57.27%
總資產收益率:-854.34%
市淨率:-0.10
市盈率(LYR):-0.02

資料載入中...

2025/01/17

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/05

SEC問詢函

Form CORRESP - Correspondence
2024/04/04

SEC問詢函

Form CORRESP - Correspondence
2024/04/03

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/30

SEC問詢函

Form CORRESP - Correspondence
2024/03/29

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/15

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/02/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/18

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/07/04

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/09

重要事件披露

8-K - Current report